1.1 http://www.docstoc.com/docs/document-preview.aspx?doc_id=8713016 1.2 http://www.docstoc.com/docs/document-preview.aspx?doc_id=8712909 2 ... more>>
Joint Platform Interior Decontamination (JPID) Description: The JPID system will decontaminate chemical and biological warfare agents on the interior ... more>>
Critical Reagents Program (CRP) Description: CRP products such as antibodies, select agent antigens, nucleic acid panels, Electrochemiluminescence (EC ... more>>
Joint Biological Agent Identification and Diagnostic System (JBAIDS) Description: The Joint Biological Agent Identification and Diagnostic System (JBA ... more>>
Medical Aerosolized Nerve Agent Antidote (MANAA) Description: MANAA (NSN 6505-01-332-1281) is an aerosol inhalant device used to administer the nerve ... more>>
Bioscavenger Increment I Plasma-derived butyrylcholinesterase Description: Nerve agents (e.g., soman, sarin, VX) are fast acting and lethal at low ... more>>
Improved Nerve Agent Treatment System (INATS) Description: The INATS is an enhanced treatment regimen designed to provide protection against a broad s ... more>>
Anthrax Vaccine Adsorbed (AVA) Description: AVA is an FDA-licensed vaccine produced by BioPort Corporation under the trade name BioThrax TM. The ... more>>
Convulsant Antidote for Nerve Agents (CANA) Description: The Food and Drug Administration approved CANA (NSN 6505-01-274-0951) is an autoinjector cont ... more>>
Advanced Anticonvulsant System (AAS) Description: The AAS consists of the drug midazolam, in an autoinjector, for treatment of nerve agentinduced seiz ... more>>
Antidote Treatment – Nerve Agent, Autoinjector (ATNAA) Description: The Food and Drug Administration-approved ATNAA (NSN 6505-01-362-7427) is a 2chamb ... more>>